Forte Biosciences, Inc. cotiza a 76.99 USD y tiene una capitalización bursátil de $1.6B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Forte Biosciences, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for autoimmune and autoimmune-related diseases. The company offers products, such as its lead product candidate FB102, a proprietary molecule with applications for celiac disease, vitiligo, and alopecia areata; and services, incl…
| Periodo | 2026-08 |
|---|---|
| Real | — |
| Estimado | $-0.88 |
| Sorpresa | — |
| Métrica | FBRX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -113.8% | -40.4% | -73.3% |
| ROA | -83.8% | -32.0% | -51.8% |
| Current Ratio | 3.88 | 2.84 | +1.04 |
| Debt / Equity | — | 0.28 | — |